Liming M. Xu

Key Laboratory Of Aquatic Animal Diseases And Immune Technology Of Heilongjiang Province, Heilongjiang River Fisheries Research Institute
Harbin, 150070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Rainbow trout (Oncorhynchus mykiss) G3BP1 function as an antiviral molecule against infectious hematopoietic necrosis virus infection.

Rainbow trout (Oncorhynchus mykiss) G3BP1 function as an antiviral molecule against infectious hematopoietic necrosis virus infection.

Journal: Fish & shellfish immunology

Published: November 05, 2025

Evaluation of protective effect of infectious hematopoietic necrosis (IHN) oral DNA vaccine wrapped with 4 different delivery vectors against IHN virus (IHNV) infection in rainbow trout (Oncorhynchus mykiss).

Evaluation of protective effect of infectious hematopoietic necrosis (IHN) oral DNA vaccine wrapped with 4 different delivery vectors against IHN virus (IHNV) infection in rainbow trout (Oncorhynchus mykiss).

Journal: Fish & shellfish immunology

Published: September 04, 2025

Targeted delivery of Bak BH3 peptide to renal myofibroblast for renal fibrosis treatment by activating the mitochondrial-dependent apoptosis pathway.

Targeted delivery of Bak BH3 peptide to renal myofibroblast for renal fibrosis treatment by activating the mitochondrial-dependent apoptosis pathway.

Journal: International immunopharmacology

Published: May 20, 2025

RETRACTED: Liu et al. Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis. Int. J. Mol. Sci. 2024, 25, 308.

RETRACTED: Liu et al. Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis. Int. J. Mol. Sci. 2024, 25, 308.

Journal: International journal of molecular sciences

Published: December 17, 2024

IPNV inactive vaccine supplemented with GEL 02 PR adjuvant: Protective efficacy, cross-protection, and stability.

IPNV inactive vaccine supplemented with GEL 02 PR adjuvant: Protective efficacy, cross-protection, and stability.

Journal: Fish & shellfish immunology

Published: July 16, 2024

Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways.

Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways.

Journal: International immunopharmacology

Published: February 01, 2024

MK-0608 inhibits in vitro and in vivo RNA replication of infectious pancreatic necrosis virus.

MK-0608 inhibits in vitro and in vivo RNA replication of infectious pancreatic necrosis virus.

Journal: Fish & shellfish immunology

Published: January 10, 2024

Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathways.

Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathways.

Journal: European journal of pharmacology

Published: December 19, 2023

Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis.

Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis.

Journal: International journal of molecular sciences

Published: November 07, 2023

Characterization of the activity of 2'-C- methylcytidine against infectious pancreatic necrosis virus replication.

Characterization of the activity of 2'-C- methylcytidine against infectious pancreatic necrosis virus replication.

Journal: Fish & shellfish immunology

Published: August 14, 2023

Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.

Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.

Journal: The protein journal

Published: August 02, 2023

Supression Thioredoxin reductase 3 exacerbates the progression of liver cirrhosis via activation of ferroptosis pathway.

Supression Thioredoxin reductase 3 exacerbates the progression of liver cirrhosis via activation of ferroptosis pathway.

Journal: Life sciences

Published: December 22, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026